Speaker Profile
PhD, MBA, CEO, ViewsML
Biography
Kenneth is CEO and co-founder of ViewsML. He previously co-founded Wax-it Histology Services, a contract research organization focused in histopathology for drug research. Kenneth has over 20 years of experience in management, product management, marketing and medical affairs. He has held various leadership roles in start-up, mid-size, and multinational life science and pharmaceutical companies. Most recently, Kenneth led global strategy, capabilities development, and Key Opinion Leader management at Eli Lilly.
Talk
Next Generation Immunohistochemistry: Multiplexing AI Virtual Biomarkers
Immunohistochemistry (IHC) and multiplexing are key for elucidating biomarker spatial expression in precision medicine. This talk will describe a novel AI-driven approach to bypass these wet lab processes to produce instant predicted virtual results. Use cases for this technology encompass translational research through to patient enrichment and stratification in clinical trials.
AI and Data Sciences Showcase:
ViewsML
ViewsML is transforming spatial biology for translational research and precision medicine using AI deep learning. By virtualizing immunohistochemistry (IHC) and biomarkers, we give researchers back 100% of their IHC time, 50% of their budget and richer data sets - representing a 15X ROI.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
